Hyperproinsulinemia: genes and variants
Explore variant evidence for Hyperproinsulinemia across 1 analyzed protein (INS). Linked ClinVar records include 6 pathogenic or likely pathogenic variants, 3 variants of uncertain significance and 1 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Hyperproinsulinemia
INS: Insulin
After processing to insulin, it lowers blood glucose by promoting cellular glucose uptake, glycogen and lipid synthesis, and suppression of hepatic glucose production. Pathogenic variants can cause neonatal diabetes, maturity-onset diabetes of the young, or hyperproinsulinemia depending on their effect on folding and secretion.
6 ClinVar pathogenic / likely pathogenic and 4 uncertain variants in INS have source records linked to Hyperproinsulinemia. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Hyperproinsulinemia
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| INS M1V | 1 | Pathogenic / likely pathogenic (★★) | |
| INS R89L | 89 | Pathogenic / likely pathogenic | |
| INS R89H | 89 | Pathogenic / likely pathogenic | |
| INS R89P | 89 | Pathogenic / likely pathogenic | |
| INS F49L | 49 | Pathogenic / likely pathogenic | |
| INS F48S | 48 | Pathogenic / likely pathogenic |
Same protein, different disease
- Diabetes mellitus also has ClinVar records linked to INS variants; they fall mostly in different places as the Hyperproinsulinemia variants (12 pathogenic / likely pathogenic).
- Diabetes mellitus, permanent also has ClinVar records linked to INS variants; they fall partly in the same places as the Hyperproinsulinemia variants (11 pathogenic / likely pathogenic).
- Maturity-onset diabetes of the young also has ClinVar records linked to INS variants; they fall mostly in different places as the Hyperproinsulinemia variants (3 pathogenic / likely pathogenic).
Diseases related to Hyperproinsulinemia
- Monogenic diabetes, also linked to INS
- Maturity-onset diabetes of the young, also linked to INS
- Type 2 diabetes mellitus, also linked to INS
- Diabetes mellitus, also linked to INS
- Diabetes mellitus, permanent, also linked to INS
- Permanent neonatal diabetes mellitus, also linked to INS
- Type 1 diabetes mellitus, also linked to INS
Frequently asked questions
Which genes have records linked to Hyperproinsulinemia?
This view contains 1 analyzed proteins: INS. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 6 pathogenic or likely pathogenic variants, 3 variants of uncertain significance and 1 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 10 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center